Applicant, as named in the Orange Book

Ge Healthcare

Next listed expiry: Optison on 9 May 2028. 2 products with live protection, 15 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Optison albumin human	albumin human	020899	9 May 2028	exclusivity
Vizamyl flutemetamol f-18	flutemetamol f-18	203137	16 Sep 2028	patent

Recent events

25 Oct 2026Omnipaque 180 · First generic approved 13 Nov 2025
25 Oct 2026Omnipaque 180 · Generic approved 13 Nov 2025

Products without listed protection (15)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Adreview iobenguane sulfate i-123	iobenguane sulfate i-123	022290	open now	no listed protection
Ceretec technetium tc-99m exametazime kit	technetium tc-99m exametazime kit	019829	open now	no listed protection
Cerianna fluoroestradiol f-18	fluoroestradiol f-18	212155	open now	no listed protection
Indium In 111 Oxyquinoline indium in-111 oxyquinoline	indium in-111 oxyquinoline	019044	open now	no listed protection
Mpi Indium Dtpa In 111 indium in-111 pentetate disodium	indium in-111 pentetate disodium	017707	open now	no listed protection
Omnipaque 12 iohexol	iohexol	018956	open now	no listed protection
Omnipaque 140 iohexol	iohexol	018956	open now	no listed protection
Omnipaque 180 iohexol	iohexol	018956	open now	no listed protection
Omnipaque 240 iohexol	iohexol	018956	open now	no listed protection
Omnipaque 300 iohexol	iohexol	018956	open now	no listed protection
Omnipaque 350 iohexol	iohexol	018956	open now	no listed protection
Omnipaque 9 iohexol	iohexol	018956	open now	no listed protection
Omniscan gadodiamide	gadodiamide	020123	open now	no listed protection
Visipaque 270 iodixanol	iodixanol	020351	open now	no listed protection
Visipaque 320 iodixanol	iodixanol	020351	open now	no listed protection